Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank M Lehmann

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Mucosal Immunology|August 3, 2021
mTOR signaling mediates ILC3-driven immunopathologyClaudia Teufel, Edit Horvath, Annick Peter, et al.
Plos One|October 17, 2013
Targeting c-MYC with T-cellsFlorian Helm, Thomas Kammertoens, Frank M Lehmann, et al.
Plos One|August 4, 2012
Humanized c-Myc mouseFrank M Lehmann, Samantha Feicht, Florian Helm, et al.
Blood Advances|January 4, 2018
Interleukins 12 and 15 induce cytotoxicity and early NK-cell differentiation in type 3 innate lymphoid cellsAna Raykova, Paolo Carrega, Frank M Lehmann, et al.
International Journal of Cancer|February 7, 2014
Targeting high-grade B cell lymphoma with CD19-specific T cellsFrank M Lehmann, Anna Maurberger, Samantha Feicht, et al.
Plos One|April 6, 2012
Stromal interferon-γ signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in miceArmin Gerbitz, Madhusudhanan Sukumar, Florian Helm, et al.
Science Signaling|May 12, 2021
ERK phosphorylation is RAF independent in naïve and activated B cells but RAF dependent in plasma cell differentiationLaura Scheffler, Samantha Feicht, Tea Babushku, et al.
Immunity|November 23, 2017
Interleukin-33-Activated Islet-Resident Innate Lymphoid Cells Promote Insulin Secretion through Myeloid Cell Retinoic Acid ProductionElise Dalmas, Frank M Lehmann, Erez Dror, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Mucosal Immunology|August 3, 2021
mTOR signaling mediates ILC3-driven immunopathologyClaudia Teufel, Edit Horvath, Annick Peter, et al.
Plos One|October 17, 2013
Targeting c-MYC with T-cellsFlorian Helm, Thomas Kammertoens, Frank M Lehmann, et al.
Plos One|August 4, 2012
Humanized c-Myc mouseFrank M Lehmann, Samantha Feicht, Florian Helm, et al.
Blood Advances|January 4, 2018
Interleukins 12 and 15 induce cytotoxicity and early NK-cell differentiation in type 3 innate lymphoid cellsAna Raykova, Paolo Carrega, Frank M Lehmann, et al.
International Journal of Cancer|February 7, 2014
Targeting high-grade B cell lymphoma with CD19-specific T cellsFrank M Lehmann, Anna Maurberger, Samantha Feicht, et al.
Plos One|April 6, 2012
Stromal interferon-γ signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in miceArmin Gerbitz, Madhusudhanan Sukumar, Florian Helm, et al.
Science Signaling|May 12, 2021
ERK phosphorylation is RAF independent in naïve and activated B cells but RAF dependent in plasma cell differentiationLaura Scheffler, Samantha Feicht, Tea Babushku, et al.
Immunity|November 23, 2017
Interleukin-33-Activated Islet-Resident Innate Lymphoid Cells Promote Insulin Secretion through Myeloid Cell Retinoic Acid ProductionElise Dalmas, Frank M Lehmann, Erez Dror, et al.
Pageof 1